EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. (EYPT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
eypt · stock forecast · 18 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 18 Wall Street analysts in the past 3 months
Buy
18 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$39.00
Consensus
$37.50
+227.5% upside
Low
$36.00
Median: $37.5 · Last Close: $11.45
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$37.50
227.5% upside
High Target
$39
240.6%
Low Target
$36
214.4%
Current Price
$11.45
as of today
Based on analyst price targets, the EYPT stock price prediction for the next 12 months ranges from $36 to $39. The consensus EYPT price forecast of $37.50 implies 227.5% upside from the current price of $11.45.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $11.01 | ↓ 3.80% |
1-day model range: $10.95–$11.08. Peak: $11.08 (-3.80%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $8 | -33.7% |
| 2028 | $6 | -46.0% |
| 2029 | $6 | -51.5% |
| 2030 | $5 | -54.2% |
| 2031 | — | -55.7% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · EYPT · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-07 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-03-09 | Citigroup | Maintains | Buy→Buy |
| 2026-03-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-04 | Chardan Capital | Maintains | Buy→Buy |
| 2025-11-06 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-08-07 | Chardan Capital | Maintains | Buy→Buy |
| 2025-08-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-16 | Mizuho | Maintains | Outperform→Outperform |
| 2025-05-08 | Chardan Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on EyePoint Pharmaceuticals, Inc. (EYPT) stock. Of the recent 68 rating actions, 2 were upgrades and 2 were downgrades. 18 analysts currently cover EYPT.
Analyst Recommendation Trends
EYPT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 99.4% YoY
Revenue Next Year
$48M
↑ 2653.6% YoY
EPS This Year
$-3.54
EPS Next Year
$-2.85
↓ 19.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast EYPT EPS of $-3.54 for the current fiscal year, based on estimates from 8 analysts. The EYPT revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The EYPT stock forecast is supported by two independent data sources: analyst consensus ratings from 18 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus EYPT price target is $37.50 (+227.5% upside), with an analyst consensus of Buy.
The EYPT short-term stock prediction for tomorrow is $11.01 (-3.80%). The EYPT stock price prediction for 2027 estimates an average of $8. The EYPT stock prediction for 2030 projects a range of $5–$6.
EyePoint Pharmaceuticals, Inc. trades on NASDAQ under the ticker EYPT. The EYPT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 89% of covering analysts.
Frequently asked questions
EYPT forecast · 8 questionsAccording to 18 Wall Street analysts, the average 12-month EYPT price target is $37.50, with a high forecast of $39.00 and a low of $36.00. The median price target is shown in the chart above when available. This implies +227.5% potential upside from the current price of $11.45.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.